Abstract
Cellular and biocellular uses of adipose-derived stem/stromal cells in plastic and reconstructive surgery and regenerative medicine have relatively recently come to forefront of the practice of medicine and surgery as a therapeutic option. The concept of “Healing Yourself with Your Own Tissues and Cells” is rapidly resulting in a paradigm shift in patient care for a very wide variety of clinical applications and patient needs. Simply put, the ability to identify and acquire important reparative cell populations and concentrate them has become of significant importance. Offering a proactive means of using the patient’s own tissues and cells is providing a major complement to traditional medication applications. Local and systemic delivery has been greatly advanced with point-of-care abilities to do such isolations and concentrations. As cellular options are evolving in studies, and better recognized in clinical trials for safety and efficacy, the day of “customized” effective therapies will be reported and expanded.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander RW. Understanding adipose-derived stromal vascular fraction (AD-SVF) cell biology and use on the basis of cellular, chemical, structural and paracrine components: a concise review. J Prolother. 2012;4(1):e855–69.
Zuk PA, Zhu M, Mizuno H, et al. Multi-lineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–38.
Zuk P. Adipose-derived stem cells in tissue regeneration: a review. ISRN Stem Cells 2013;2013:35 pages. Article ID 713959.
Alexander RW. Understanding adipose-derived stromal vascular fraction (SVF) cell biology in reconstructive and regenerative applications on the basis of mononucleated cell components. J Prolother. 2013;10:15–29.
Alderman D, Alexander RW, Harris G. Stem cell prolotherapy in regenerative medicine: background, research, and protocols. J Prolother. 2011;3(3):689–708.
Sadati KS, Corrado AC, Alexander RW. Platelet-rich plasma (PRP) utilized to promote greater graft volume retention in autologous fat grafting. Am J Cosmet Surg. 2006;23(4):627–31.
Alexander RW. Use of PRP in autologous fat grafting. In: Shiffman M, editor. Autologous fat grafting, vol. 14. Berlin: Springer; 2010. p. 87–112.
Alexander RW. Biocellular regenerative medicine: use of adipose-derived stem/stromal cells and it’s bioactive matrix. Phys Med Rehabil Clin North America. 2016;27:871–91.
Blaber S, Webster R, Cameron J, et al. Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med. 2012;10:172.
Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301–13.
Guilak F, Cohen DM, Estes BT, Gimble JM, Liedtke W, Chen CS. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell. 2009;5(1):17–26.
Brizzi M, Tarone G, Defilippi P. Extracellular matrix, integrins, and growth factors as tailors of stem cell niche. Curr Opin Cell Biol. 2012;24(5):645–51.
Soo-Yyun K, Turnbull J, Guimond S. Extracellular matrix and cell Signaling: the dynamic cooperation of integrin, proteoglycan, and growth factor receptor. J Endocrinol. 2011;209:139–51.
Alexander RW. Fat transfer with platelet-rich plasma for breast augmentation. In: Shiffman M, editor. Breast augmentation: principles and practice. Berlin: Springer; 2009. p. 451–70.
Kato H. Short- and long-term cellular events in adipose tissue remodeling after non-vascularized grafting. Paper presented at the International Federation for Adipose Therapeutics and Science Miami, 9th Annual Symposium on Adipose Stem Cells and Clinical Applications of Adipose Tissue; 2011 Nov 4–6; Miami, Florida, USA.
Alexander RW. Liposculpture in the superficial plane: closed syringe system for improvement in fat removal and free fat transfer. Am J Cosm Surg. 1994;11(2):127–34.
Alexander RW, Harrell DB. Autologous fat grafting: use of closed syringe microcannula system for enhanced autologous structural grafting. Clin Cosmet Investig Dermatol. 2013;6:91–102.
Alexander R. Unpublished data. 2019.
Kurita M, Matsumoto D, Shigeura T, et al. Influences of centrifugation on cells and tissues in liposuction aspirates: optimized centrifugation for lipotransfer and cell isolation. Plast Reconstr Surg. 2008;121(3):1033–41.
Alexander RW. Introduction to biocellular medicine. In: Moore R, editor. Sonography of the extremities: techniques & protocols. 4th ed. Cincinnati: General Musculoskeletal Imaging Inc.; 2015. p. 97–104.
Eto H, Suga H, Inoue K, et al. Adipose injury-associated factors mitigate hypoxia in ischemic tissues through activation of adipose-derived stem/progenitor/stromal cells and induction of angiogenesis. Am J Pathol. 2011;178(5):2322–32.
Alexander RW. Understanding mechanical emulsification (nanofat) versus enzymatic isolation of tissue stromal vascular fraction (tSVF) cells from adipose tissue: potential uses in biocellular regenerative medicine. J Prolother. 2016;8:e947–60.
Oliver K, Alexander RW. Combination of autologous adipose-derived tissue stromal vascular fraction plus high-density platelet-rich plasma or bone marrow concentrates in Achilles tendon tears. J Prolother. 2013;5:e895–912.
Albano J, Alexander RW. Autologous fat grafting as a mesenchymal stem cell source and living bioscaffold in a patellar tendon tear. Am J Sports Med. 2011;21(4):359–61.
Alderman D, Alexander RW. Advances in regenerative medicine: high-density platelet-rich plasma and stem cell prolotherapy. J Pract Pain Management. 2011;10:49–90.
Alexander RW. Autologous fat grafts as mesenchymal stromal stem cell source for use in prolotherapy: a simple technique to acquire lipoaspirants. J Prolother. 2011;3(3):680–8.
Jackson M, Morrison D, Doherty D, et al. Mitochondrial transfer via tunneling nanotubes is important mechanism by which mesenchymal stem cells enhance macrophage phagocytosis in the in vitro and in vivo models or ARDS. Stem Cells. 2016;34:2210–23.
Alexander RW. Use of software analytics of brain MRI (with & without contrast) as objective metric in neurological disorders and degenerative diseases. Int Phys Med Rehab J. 2017;2(2):41–4. https://doi.org/10.15406/ipmrj.2017.02.00046.
Tobita M, Tajima S, Mizuno H. Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness. Stem Cell Res Ther. 2015;6:215–22.
Alexander RW. Use of PIXYL software analysis of brain magnetic resonance imaging (with & without contrast) as valuable metric in clinical trial tracking in study of multiple sclerosis (MS)and related neurodegenerative processes. Clin Trial Degen Dis. 2017;2(1):1–7.
Lamichhane T, Sokic S, Schardt J, et al. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tiss Eng B Rev. 2015;21(1):45–54.
Tonnard P, et al. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;152:1017–26.
Acknowledgements
The author wishes to thank our clinical and laboratory staff, Ms. Nancy L. Smith and Ms. Susan Riley, for their endless hours and efforts in order to facilitate patients, sample gathering, and testing. Without such devotees, clinical papers cannot be reported.
There are no conflicts of interest reported in this chapter or its content.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alexander, R.W. (2019). Adipose Tissue Complex (ATC): Cellular and Biocellular Uses of Stem/Stromal Cells and Matrix in Cosmetic Plastic, Reconstructive Surgery and Regenerative Medicine. In: Duscher, D., Shiffman, M.A. (eds) Regenerative Medicine and Plastic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-19962-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-19962-3_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19961-6
Online ISBN: 978-3-030-19962-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)